Guide to virtual screening: application to the Akt phosphatase PHLPP.

Area of Science:

• Biochemistry
• Pharmacology
• Computational Chemistry

Background:

• The Akt signaling pathway is crucial for cell growth and survival.
• PHLPP (PH domain Leucine repeat Protein Phosphatase) antagonizes Akt and PKC kinases.
• Dysregulation of these pathways is implicated in cancer, diabetes, and cardiovascular diseases.

Purpose of the Study:

• To identify novel inhibitors of PHLPP, a potential therapeutic target.
• To evaluate the efficacy of virtual screening (VS) techniques in discovering PHLPP inhibitors.
• To compare the performance of virtual screening against traditional chemical screening.

Main Methods:

• Utilized virtual screening (VS) with GLIDE docking software.
• Screened a library of over 40,000 compounds from the NCI depository.
• Employed similarity searches for compound library selection.
• Combined VS with chemical screening approaches.
• Tested identified compounds in cellular assays for PHLPP inhibition and cell death prevention.

Main Results:

• Identified multiple compounds with diverse scaffolds that inhibit PHLPP.
• These compounds demonstrated binding to PHLPP.
• Inhibiting compounds successfully prevented cell death in cellular assays.
• Quantified and compared enrichment factors of VS versus chemical screening.

Conclusions:

• Virtual screening is an effective method for identifying PHLPP inhibitors.
• The identified compounds represent promising leads for therapeutic development.
• Further research into PHLPP inhibitors could lead to new treatments for cancer and metabolic diseases.